342 filings
Page 8 of 18
8-K
en5ngr4ftn
20 May 10
Departure of Directors or Certain Officers
12:00am
8-K
vdy4zttnvwoiatj5
10 May 10
ARIAD Reports First Quarter 2010 Financial Results and Development Progress
12:00am
8-K
8xt idr0uz3
6 May 10
ARIAD Announces Restructuring of Its Ridaforolimus Collaboration with Merck
12:00am
8-K
ji5s4w ng1qtk8mgcy4
3 May 10
Departure of Directors or Certain Officers
12:00am
8-K
j2kjs39h47hy6xdjo gn
15 Apr 10
ARIAD Names Robert Whelan, Jr. to Board of Directors
12:00am
8-K
76dak4g7ditmq8mt
23 Mar 10
ARIAD Announces Court Ruling Regarding NF-κB Patent Lawsuit with Lilly
12:00am
8-K
myzml
16 Mar 10
ARIAD Reports Development Progress and Fourth Quarter and Year-End 2009 Financial Results
12:00am
8-K
2pj5om2b
1 Mar 10
ARIAD Receives Orphan Drug Designations for Its Investigational pan BCR-ABL Inhibitor, AP24534, in Chronic Myeloid Leukemia
12:00am
8-K
kzqt 056vk5b77
22 Jan 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
pa94 0yvrp0iu
17 Dec 09
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
12:00am
8-K
tqzvfypws7lvh2xn
15 Dec 09
Other Events
12:00am
8-K
ncd 4sd9uwg
7 Dec 09
ARIAD Presents Positive Clinical Proof-of-Concept Data on AP24534 in Drug-Resistant Hematological Cancers at ASH Annual Meeting
12:00am
8-K
5ob hhpzggotqgwhz
5 Nov 09
ARIAD Reports Third Quarter 2009 Development Progress and Financial Results
12:00am
8-K
1owo8nu im
23 Sep 09
ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab
12:00am
8-K
fnhw9ww2
27 Aug 09
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
fx2c ryijdd16s71fo1r
4 Aug 09
Ariad Prices Public Offering of Common Stock
12:00am
8-K
ad1wovfe6irpifh12ad
3 Aug 09
Ariad Announces Proposed Public Offering of Common Stock
12:00am
8-K
u4fdpixxpp55 mzl71xt
30 Jul 09
Ariad Reports Second Quarter 2009 Financial Results and Development Progress
12:00am
8-K
w3ues
28 Jul 09
Other Events
12:00am
8-K
2z16bz9z8pech1qlig
25 Jun 09
Departure of Directors or Certain Officers
12:00am